What is Evommune 's amortization expense?

Evommune (EVMN) reported amortization expense of -$87.88K in Q1 2026.

What does amortization expense mean?

Amortization expense is the systematic allocation of the cost of intangible assets or capitalized software over their useful lives. This non-cash charge reduces the carrying value of assets on the balance sheet and impacts reported net income. Monitoring this expense helps investors understand the ongoing cost of maintaining the company's technological and intellectual property base.

Evommune EVMN Amortization Expense

Amortization Expense at other companies

Cadence Design SystemsCDNS

$20.21M+127%

Sotera HealthSHC

$3.03M-80.2%

PDF SolutionsPDFS

$2.06M+94.8%

Electronic ArtsEA

$15M-11.8%

John Wiley & Sons, Inc.WLYB

$13.25M+2.7%

BlockXYZ

$34.16M+1.5%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+42.8%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept meha:AmortizationExpense.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's amortization expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's amortization expense?: Evommune (EVMN) reported amortization expense of -$87.88K in Q1 2026.
What does amortization expense mean?: Amortization expense is the systematic allocation of the cost of intangible assets or capitalized software over their useful lives. This non-cash charge reduces the carrying value of assets on the balance sheet and impacts reported net income. Monitoring this expense helps investors understand the ongoing cost of maintaining the company's technological and intellectual property base.